Verwijzer
Sebastiaan ter Burg

Most likely you, or one of your patients, was recently diagnosed with NET. NET is rare, and every NET is different. It is so infrequent that a GP on average only sees 1 or 2 patients with this form of cancer during his career.

 

For a PRRT treatment with good results, it is important that you go to a specialist with experience in treating NET patients.

 

PRRT Treatment Center Rotterdam is internationally accredited by the international association of neuroendocrine tumor specialists ENETS. We treat around 100 patients per year, with good results.

 

For a visual overview of the different steps before, during and after treatment, view the following schematic representations:

 Infographic-1-From-diagnosis-to-intake Infographic-2-Intake-&-Treatment

Go to the page with required information needed for treatment.
Or go directly to the contact page for referring physicians.

Requirements PRRT Treatment

Patients with somatostatin receptor positive tumors can in principle be treated with PRRT. Most often these patients have a neuroendocrine tumor (NET). Most patients have a NET of the small intestine (carcinoid) or of the pancreas.

 

PRRT treatment is primarily used to treat metastasized or inoperable grade 1 or grade 2 (relatively slow growing) tumors. Grade 3 tumors are generally treated with chemotherapy. Read more about the treatment or about the grading of NETs.

Indications to start with PRRT

A waiting approach is often best the best approach for patients with NET. The indications for starting PRRT treatment are progression of the disease, high tumor burden/load and a symptoms that cannot be managed by medication. In some cases where the pancreas cannot be operated upon, PRRT can be applied in a neoadjuvant setting, hopefully leading to a decreased tumor size so that surgery is possible.

 

Find more information about: